Daniel W. Lin

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Engineered high-density lipoprotein particles that chaperone bioactive lipid mediators to combat endothelial dysfunction and thromboinflammation”.

Engineered high-density lipoprotein particles that chaperone bioactive lipid mediators to combat endothelial dysfunction and thromboinflammation

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.14.480375

N/A

0.117DataRank · unranked

1 citations

Daniel W. Lin, Shihui Guo, Alan Culbertson, Andrew Kuo, Michel V. Levesque +11 more

RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer

Cancer Research(2021)10.1158/0008-5472.can-21-0307

N/A

0DataRank · unranked

53 citations

Lisha G. Brown, Ilsa M. Coleman, Bryce Lakely, Nicholas J. Brady, John K. Lee +13 more

Genetic factors associated with prostate cancer conversion from active surveillance to treatment

Human Genetics and Genomics Advances(2021)10.1016/j.xhgg.2021.100070

N/A

0DataRank · unranked

23 citations

Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki +92 more

Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer

Cancer(2021)10.1002/cncr.33911

N/A

0DataRank · unranked

8 citations

Kehao Zhu, Yingye Zheng, Lisa F. Newcomb, Jeannette M. Schenk, James D. Brooks +15 more

Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment

medRxiv(2021)10.1101/2021.08.30.21262305

N/A

0DataRank · unranked

14 citations

Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki +92 more

Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis

Human Pathology(2022)10.1016/j.humpath.2022.01.009

N/A

0DataRank · unranked

25 citations

Yan Gao, Yi Ding, Ping Bu, Brian J. Miles, Angelo De Marzo +25 more

Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance

Cancer Medicine(2022)10.1002/cam4.4778

N/A

0DataRank · unranked

10 citations

Lisa F. Newcomb, Kehao Zhu, Yingye Zheng, Hilary Boyer, Navonil De Sarkar +16 more

Rates of germline genetic testing and DNA damage response mutations found through population-based recruitment of men with incident metastatic prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10501

N/A

0DataRank · unranked

3 citations

Risa Liang Wong, Burcu F. Darst, Colin C. Pritchard, Peter S. Nelson, Janet L. Stanford +3 more

Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0250

N/A

0DataRank · unranked

19 citations

Nathan A. Lau, Alicia Wong, Lisha G. Brown, Ilsa M. Coleman, Navonil De Sarkar +14 more

Targeting the fibroblast growth factor pathway in molecular subtypes of castration‐resistant prostate cancer

The Prostate(2023)10.1002/pros.24630

N/A

0DataRank · unranked

12 citations

Lisha G. Brown, Ilsa M. Coleman, Holly M. Nguyen, Susan L. Dalrymple, W. Nathaniel Brennen +11 more

Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study

Modern Pathology(2023)10.1016/j.modpat.2023.100241

N/A

0DataRank · unranked

8 citations

Stephanie A. Harmon, Rachael Iseman, Olga Ludkowski, Heidi Auman, Sarah T. Hawley +28 more

Constructing Time-Invariant Dynamic Surveillance Rules for Optimal Monitoring Schedules

Biometrics(2023)10.1111/biom.13911

N/A

0DataRank · unranked

2 citations

Yingye Zheng, Daniel W. Lin, Lisa F. Newcomb, Ying‐Qi Zhao, Xinyuan Dong

Prostate-specific antigen value at 3 & 7 months (PSA-3mo, PSA-7mo) and overall survival (OS) in metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen deprivation (ADT) with or without orteronel (SWOG S1216).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5074

N/A

0DataRank · unranked

2 citations

Catherine M. Tangen, Maha Hussain, Shilpa Gupta, Yeonjung Jo, Andrea Harzstark +15 more

Data from Expression of SLCO Transport Genes in Castration-Resistant Prostate Cancer and Impact of Genetic Variation in SLCO1B3 and SLCO2B1 on Prostate Cancer Outcomes

(2023)10.1158/1055-9965.c.6515046.v1

N/A

0DataRank · unranked

0 citations

Erika M. Kwon, Elaine A. Ostrander, Bruce Montgomery, Daniel W. Lin, Robert L. Vessella +3 more

High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker

Scientific Reports(2024)10.1038/s41598-023-50215-z

N/A

0DataRank · unranked

11 citations

Sarah Hawley, Christian A. Kunder, En‐Chi Hsu, Michelle Shen, Lennart Westphalen +17 more

Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide

European Urology Oncology(2024)10.1016/j.euo.2024.03.001

N/A

0DataRank · unranked

9 citations

Catherine M. Tangen, Maha Hussain, Shilpa Gupta, Sam Callis, Yeonjung Jo +17 more

Phase 1/2 Randomized Clinical Trial of In-clinic acupuncture Prior to Bacillus Calmette-Guérin in Patients with High-risk Non–muscle-invasive Bladder Cancer

European Urology Oncology(2024)10.1016/j.euo.2024.04.002

N/A

0DataRank · unranked

1 citations

Susan Veleber, Jonathan Siman, Sarah K. Holt, Samia Jannat, Jonathan L. Wright +6 more

Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.07.024

N/A

0DataRank · unranked

2 citations

Elizabeth Koehne, Jenna Voutsinas, Leonidas Nikolaos Diamantopoulos, Dimitrios Makrakis, Petros Grivas +19 more

Neoadjuvant pembrolizumab (pembro) and accelerated methotrexate, vinblastine, doxorubicin, cisplatin (aMVAC) in non-urothelial (non-UC) histologic subtype muscle invasive bladder cancer (MIBC): A phase 2 trial.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.769

N/A

0DataRank · unranked

2 citations

Ali Raza Khaki, Mary W. Redman, Kelsey K. Baker, Aaron Lin, Brianna Woo +15 more

Assessment of postoperative practices and discharge recommendations after radical prostatectomy

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.03.027

N/A

0DataRank · unranked

0 citations

Melissa Assel, Maria Pere, Sunny Nalavenkata, Karim Touijer, Vincent P. Laudone +5 more

Estimating optimally tailored active surveillance strategy under interval censoring

Biometrics(2025)10.1093/biomtc/ujaf067

N/A

0DataRank · unranked

0 citations

Ying‐Qi Zhao, Daniel W. Lin, Matthew R. Cooperberg, Yingye Zheng, Muxuan Liang

Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2020.10.002

N/A

0DataRank · unranked

19 citations

Sarah K. Holt, Ali Raza Khaki, Rishi Sekar, Adam J. Gadzinski, Yaw A. Nyame +17 more

Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations

European Urology Focus(2025)10.1016/j.euf.2025.11.011

N/A

0DataRank · unranked

0 citations

Sam Callis, Evan Y. Yu, Scott E. Delacroix, Alexandra Sokolova, Catherine M. Tangen +4 more